Browsing: Oligometastatic

Top Line: Results of the phase II EXTEND trial were initially presented in abstract form at last year’s ASTRO annual…

Rather than blaming progression after ablative radiotherapy on radiation-induced seeding, this editorial argues for a more nuanced dynamic model. Drawing…

A meta-analysis of 13 studies (n=984) evaluating SBRT alone with no up-front systemic therapy for patients with ≤5 metastases across…

By now we are all familiar with the many ways radiation can benefit patients in the oligometastatic setting beyond palliative.…

A meta-analysis of 15 prospective trials randomizing patients to +/- local therapy for oligometastases demonstrates such an intervention slashes progression-free…

Patients aren’t the only ones holding their breath during ablative radiation delivery for targets immediately below the diaphragm. Here is…

SABR-5 is the protocol that keeps giving. This interesting secondary analysis reveals outcomes for ultracentral versus peripheral lung mets are…

A propensity score matched retrospective analysis of 251 patients receiving definitive surgery (n=173) or ablative radiation (n=78) for lung mets…

We’ve said it before, and we’ll say it again: ablative radiation to adrenal mets is tricky. Here is a helpful…

Top Line: Does SBRT improve progression free survival in patients with oligoprogressive cancer?The Study: The CURB trial, first presented at…